Allosteric MAPKAPK2 inhibitors improve plaque stability in advanced atherosclerosis. - Ozcan, Lale; Kasikara, Canan; Yurdagul, Arif; Kuriakose, George; Hubbard, Brian; Serrano-Wu, Michael H.; Tabas, Ira (PLoS ONE, 2021)